A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria
Clinical trial NCT04020653 · WITHDRAWN
Trial details
- NCT number
- NCT04020653
- Sponsor
- Neopharma Japan Co., Ltd.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-06
- Primary completion
- 2020-05-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.